Post-hoc tests showed that the average area of synaptophysin staining was significantly larger in the CA3 sub-region of CML group (p<0.01, n=16) compared to the control group (n=15, Fig. 1C). The gene discussed is SYP; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.